Explore practical insights and real-world perspectives on advocacy, research, and digital health. From strengthening patient engagement to driving innovation, these articles share ideas that move healthcare forward.
On September 22, CMS cancelled roughly 315,000 Marketplace enrollments covering more than 760,000 people, and the agency published no consumer notification process and no appeals pathway in either the press release or the fact sheet it...
Four companies now control 75 percent of the national pharmacy benefit market. Two years ago they held 70 percent. Every patient who opened a surprise formulary letter this year dealt with one of those four, whatever the letterhead said.
Twelve utilization review nurses at Montefiore Medical Center went on strike earlier this year. Their new contract included language requiring nurse input when management introduced new technology such as artificial intelligence. Then came...
Matt dives into a specific healthcare topic to help those in the industry, and those outside of it, better understand the market drivers causing today's healthcare challenges.
Matt dives into a specific healthcare topic to help those in the industry, and those outside of it, better understand the market drivers causing today's healthcare challenges.
July put the structural machinery of healthcare on the table at once. The 340B program crossed 100 billion dollars, a state audit caught a PBM running a shell game, physician pay fell again, and advocacy fought to stay in the room while
Matt dives into a specific healthcare topic to help those in the industry, and those outside of it, better understand the market drivers causing today’s healthcare challenges.
Matt dives into a specific healthcare topic to help those in the industry, and those outside of it, better understand the market drivers causing today’s healthcare challenges.
Matt dives into a specific healthcare topic to help those in the industry, and those outside of it, better understand the market drivers causing today’s healthcare challenges.
Four mechanisms moved in the same month, and every one of them decides whether a patient reaches treatment. A peer-reviewed study on what happens after a pharmacy rejects a prescription. A cost analysis showing one drug carrying three
Legislation and policy seem to leave patient care behind. April 2026 told us where the policy window opened, where the system extracted more, and what advocates need to do about both.
After everything I have lived through as a patient, I can say this very simply: excellent providers make you feel safer, stronger, and more informed. They do not just treat illness. They help restore dignity.
Healthcare today is focused on AI, digital tools, and vast datasets. But data is not enough; the real challenge is turning powerful insights into meaningful change.
In the evolving landscape of patient advocacy, professionals must amplify their voice. Our new white paper, "Bridging the Gap," provides a framework for greater impact.
The BIOADVOCATE benchmark report reveals two key "ahas" about pharma advocacy. The findings make it clear: the industry must rethink its team and budget structures.
The ELAVAY and BIOADVOCATE benchmark reports offer critical feedback to pharma from the nonprofit sector, revealing key insights for revolutionizing advocacy.
In healthcare, context is key. Social determinants of health (SDOH) significantly influence patient outcomes, and addressing them is essential for real transformation.
Patient advocacy teams play a critical role in shaping outcomes, but their own voices are often unheard. We must support these teams to amplify their real impact.
The industry has improved patient inclusion, but a seat at the table is not enough. True progress requires building systems where patients can actively participate and lead.
True healthcare innovation cannot be rooted in data alone; it demands humanity. Co-creating solutions with patients is the only way to ensure new ideas succeed.
Healthcare isn't just about data and technology; it's about people. True progress is impossible without empathy, a crucial strategic advantage in modern healthcare.
Patient inclusion is now essential, but it often becomes mere tokenism. To achieve real progress, we must move beyond formality and foster true patient partnerships.
Trust is the foundation of every meaningful healthcare interaction. In a system where it’s easily broken, rebuilding it requires a commitment to near-perfection.
Cell and gene therapies are groundbreaking medical advances. Their complexity demands flawless account management to ensure successful patient access and delivery.
In 2025, the healthcare sector faces rapid transformation. Evolving patient needs and new science demand a renewed focus on innovation and strategic collaboration.
Pharma has long promoted patient-centricity as a guiding value. Yet behind the promises, the reality is clear: patient engagement remains severely lacking.
Healthcare today is focused on AI, digital tools, and vast datasets. But data is not enough; the real challenge is turning powerful insights into meaningful change.
The BIOADVOCATE benchmark report reveals two key "ahas" about pharma advocacy. The findings make it clear: the industry must rethink its team and budget structures.
The ELAVAY and BIOADVOCATE benchmark reports offer critical feedback to pharma from the nonprofit sector, revealing key insights for revolutionizing advocacy.
True healthcare innovation cannot be rooted in data alone; it demands humanity. Co-creating solutions with patients is the only way to ensure new ideas succeed.
In 2025, the healthcare sector faces rapid transformation. Evolving patient needs and new science demand a renewed focus on innovation and strategic collaboration.
Legislation and policy seem to leave patient care behind. April 2026 told us where the policy window opened, where the system extracted more, and what advocates need to do about both.
After everything I have lived through as a patient, I can say this very simply: excellent providers make you feel safer, stronger, and more informed. They do not just treat illness. They help restore dignity.
In the evolving landscape of patient advocacy, professionals must amplify their voice. Our new white paper, "Bridging the Gap," provides a framework for greater impact.
In healthcare, context is key. Social determinants of health (SDOH) significantly influence patient outcomes, and addressing them is essential for real transformation.
Patient advocacy teams play a critical role in shaping outcomes, but their own voices are often unheard. We must support these teams to amplify their real impact.
The industry has improved patient inclusion, but a seat at the table is not enough. True progress requires building systems where patients can actively participate and lead.
Healthcare isn't just about data and technology; it's about people. True progress is impossible without empathy, a crucial strategic advantage in modern healthcare.
Patient inclusion is now essential, but it often becomes mere tokenism. To achieve real progress, we must move beyond formality and foster true patient partnerships.
Trust is the foundation of every meaningful healthcare interaction. In a system where it’s easily broken, rebuilding it requires a commitment to near-perfection.
Cell and gene therapies are groundbreaking medical advances. Their complexity demands flawless account management to ensure successful patient access and delivery.
Pharma has long promoted patient-centricity as a guiding value. Yet behind the promises, the reality is clear: patient engagement remains severely lacking.
